Nuclear Stress Test: What It Is and What to Expect

A nuclear stress test is a cardiac imaging procedure that uses a small amount of radioactive tracer and a specialized camera to show how well blood flows through your heart muscle, both at rest and under physical or pharmacological stress. It is one of the most commonly used tools in cardiology for diagnosing and managing coronary artery disease.

According to the American Society of Nuclear Cardiology (ASNC), nuclear stress testing provides clinicians with information about both blood flow and heart muscle function that a standard exercise ECG alone cannot deliver. Roughly 9 million myocardial perfusion imaging studies are performed annually in the United States, making it one of the most frequently ordered cardiac diagnostic tests in the country.

Do not miss this: What Is a Cardiac Stress Test? A Complete 2026 Guide

This article explains exactly what a nuclear stress test is, how the imaging works, what the two major types (SPECT and PET) involve, what pharmacological stress agents do, how to prepare, and what your results actually mean. It also covers the honest accuracy data, the sex-specific limitations of the test that most patient-facing resources leave out, and the clinical steps that follow an abnormal result.

What Is a Nuclear Stress Test?

A nuclear stress test is a non-invasive cardiac imaging study that uses a radioactive tracer injected into the bloodstream to produce detailed pictures of blood flow through the heart muscle at rest and during stress.

The radioactive tracer travels through the coronary arteries and gets absorbed by the myocardium (heart muscle) in proportion to the amount of blood flowing to each region. A specialized gamma camera, known as a SPECT or PET scanner depending on the protocol, detects the tracer’s radiation and constructs three-dimensional perfusion maps of the heart.

Think of it like a traffic report for your coronary arteries. Normal arteries act like an open highway: the tracer flows freely and the heart muscle lights up evenly. A narrowed or blocked artery creates the equivalent of a road closure. The tracer reaches that zone in lower concentrations, and the corresponding heart muscle appears darker or absent on the images.

The test captures two sets of images: one at rest and one after the heart is stressed. Comparing those two sets tells cardiologists whether blood flow problems are caused by dynamic ischemia (reduced flow only under demand) or permanent damage (reduced flow even at rest).

Key facts about nuclear stress testing:

• Tracer substances include Tc-99m-sestamibi, Tc-99m-tetrofosmin, thallium-201 (Tl-201), and for PET imaging, rubidium-82 (Rb-82) or N-13 ammonia
• Two image sets are always compared: resting perfusion and stress perfusion
• The test also measures left ventricular ejection fraction (LVEF), a measure of how well the heart pumps with each beat
• Radiation exposure is low: approximately 9 to 12 millisieverts for a standard SPECT study and 3 to 6 millisieverts for a PET study, comparable to 1 to 4 years of background environmental radiation

People with pacemakers, prior coronary bypass surgery, or diabetes can still undergo nuclear stress testing. The protocol is adjusted based on their specific circumstances.

What Is a Nuclear Stress Test for the Heart?

A nuclear stress test for the heart is specifically designed to detect myocardial ischemia (insufficient blood supply to heart muscle) and to identify regions of the heart that have been permanently damaged by a prior heart attack.

The heart has four main chambers, but the test focuses on the left ventricle: the chamber responsible for pumping oxygen-rich blood out to the entire body. The coronary arteries, three major vessels and their branches, supply the left ventricular muscle with blood. When any of those arteries develop significant narrowing from atherosclerosis (plaque buildup inside the artery walls), the downstream heart muscle can be starved of blood during periods of high oxygen demand.

At rest, a partially narrowed artery may still deliver enough blood to keep the muscle functioning normally. Under the increased demand of exercise or pharmacological stress, the same narrowing becomes limiting. The area of muscle supplied by that artery gets less blood than it needs. That relative deficit shows up clearly on the perfusion images.

The test also measures how the heart’s pumping function changes between rest and stress. A normally perfused heart typically maintains or slightly increases its ejection fraction during stress. A heart with ischemia may show a drop in ejection fraction under stress. This drop, known as a transient ischemic dilation or stress-induced wall motion abnormality, adds clinically useful diagnostic information on top of the perfusion images.

For older adults with multiple cardiovascular risk factors, nuclear stress testing provides risk stratification beyond symptoms alone. Patients whose test shows a large zone of ischemia face meaningfully higher risk of cardiac events than those with a small, single-vessel defect.

What Is the Purpose of a Nuclear Stress Test?

The purpose of a nuclear stress test is to determine whether the blood supply to the heart muscle is adequate under conditions of increased demand, and to identify areas of permanent damage from prior heart attacks.

That description covers three distinct clinical uses. The first is diagnosis: determining whether chest pain, shortness of breath, or exertional symptoms are caused by coronary artery disease. The second is risk stratification: quantifying how severe a patient’s coronary artery disease is and estimating their risk of a future cardiac event. The third is treatment monitoring: assessing whether a prior intervention such as angioplasty, stent placement, or coronary artery bypass grafting has successfully restored blood flow.

According to guidance published by the American College of Cardiology (ACC) and the American Heart Association (AHA) on stable ischemic heart disease, nuclear stress testing with myocardial perfusion imaging is particularly valuable in patients with an intermediate pre-test probability of coronary artery disease: those for whom clinical history and basic risk factors alone do not clearly point toward or away from significant disease.

The test also helps guide revascularization decisions. Cardiologists use the size and location of perfusion deficits to determine whether a patient’s symptoms are attributable to a specific coronary artery lesion, and whether opening that lesion through stenting or bypass surgery would relieve the blood flow problem.

Nuclear stress testing has one more purpose that is easily overlooked: the prognostic value of a normal result. A completely normal nuclear stress test, with uniform tracer uptake at rest and stress and a preserved ejection fraction, carries a very low annual risk of major cardiac events (generally below 1% per year, according to data published in the Journal of Nuclear Medicine). This can be reassuring and may allow the cardiologist to defer invasive testing.

Why Would a Doctor Order a Nuclear Stress Test?

A doctor orders a nuclear stress test when they need detailed information about coronary blood flow that cannot be obtained from a standard exercise ECG or a physical examination alone.

The most common reasons for referral include unexplained chest pain, shortness of breath during exertion, palpitations associated with physical activity, and new-onset symptoms in a patient with known cardiovascular risk factors such as hypertension, diabetes, hyperlipidemia, or a family history of early heart disease.

A doctor may also choose a nuclear stress test over a standard exercise ECG in specific clinical situations. According to the StatPearls clinical reference published by the National Library of Medicine, pharmacological nuclear stress testing is indicated when a patient cannot exercise adequately due to orthopedic limitations, peripheral artery disease, or deconditioning, or when the resting ECG has abnormalities (such as a left bundle branch block or ventricular pacing) that make ECG interpretation during exercise unreliable.

Common reasons a cardiologist orders a nuclear stress test:

• New or worsening chest pain or chest pressure with physical activity
• Unexplained shortness of breath, particularly with exertion
• Palpitations or dizziness during exercise
• Pre-operative cardiac risk assessment before major non-cardiac surgery in high-risk patients
• Evaluation of known coronary artery disease to assess ischemia burden
• Monitoring heart function after coronary stenting or bypass surgery
• Assessment of patients with new-onset left bundle branch block on ECG
• Evaluation of patients presenting 3 months after an acute coronary syndrome treated conservatively

Patients with diabetes deserve a specific note. Diabetic autonomic neuropathy can blunt the normal pain response to ischemia, meaning some patients with diabetes experience no chest pain even during significant coronary blood flow restriction. A cardiologist may lower the threshold for ordering nuclear stress testing in this population because the absence of symptoms does not rule out ischemia.

Key Takeaway: A nuclear stress test produces two sets of heart images, comparing blood flow at rest and under stress, and also measures ejection fraction. A normal result carries a very low short-term cardiac event risk. An abnormal result guides the next step in diagnosis or treatment.

How Is a Nuclear Stress Test Done?

A nuclear stress test is performed in two phases: a resting image acquisition and a stress image acquisition, separated by a period of tracer uptake.

The procedure is performed in a nuclear cardiology or nuclear medicine department, staffed by a nuclear medicine technologist who administers and manages the radiotracer, a registered nurse or cardiology nurse who places the IV and monitors vital signs, and a board-certified nuclear cardiologist or nuclear medicine physician who supervises the study and interprets the images.

To understand how it works mechanically: the radioactive tracer is absorbed by heart muscle cells in proportion to blood flow. Regions receiving normal blood flow absorb the tracer at full concentration. Regions with reduced flow absorb less tracer and appear as darker zones on the perfusion scan. A gamma camera rotates around the patient’s chest, detecting the radiation emitted by the tracer from multiple angles, then reconstructs those signals into three-dimensional images of the heart.

Here is the general step-by-step sequence for a standard SPECT nuclear stress test:

1. Arrive fasting, with IV access placed in the arm. Monitoring electrodes (ECG leads) are attached to the chest.
2. The resting tracer injection is given intravenously. The patient rests quietly for 30 to 60 minutes while the tracer circulates and absorbs into the heart muscle.
3. Resting images are acquired. The patient lies still under the gamma camera for approximately 15 to 20 minutes.
4. The stress phase begins: either treadmill exercise to target heart rate or pharmacological stress agent infusion.
5. At peak stress, the second tracer injection is given. If exercising, the patient continues for 1 additional minute after injection to ensure tracer uptake at maximal flow.
6. The patient rests for 15 to 30 minutes after stress. Stress images are then acquired under the gamma camera.
7. A nuclear cardiologist reviews both image sets side by side, compares perfusion patterns, and calculates ejection fraction from gated images.

For patients with obesity or very large body habitus, the gamma camera’s photons may be attenuated by body mass, reducing image quality. Clinicians may recommend a PET study instead, which uses higher-energy photons and built-in attenuation correction, producing clearer images regardless of body size.

What Does a Nuclear Stress Test Consist Of: SPECT vs. PET Explained

A nuclear stress test consists of two core components: radiotracer injection and cardiac imaging, with the imaging performed by either a SPECT or a PET scanner, each using different radiotracers and different detection technology.

SPECT (Single-Photon Emission Computed Tomography) is the more widely available option. It uses tracers such as Tc-99m-sestamibi (brand name Cardiolite) or Tc-99m-tetrofosmin, both labeled with technetium-99m, a radioactive isotope with a 6-hour half-life and an energy of 140 kiloelectron volts. A rotating gamma camera captures the photons emitted by the tracer from multiple angles and reconstructs perfusion maps of the heart.

PET (Positron Emission Tomography) uses higher-energy tracers such as rubidium-82 (Rb-82) or N-13 ammonia. Rb-82 has a half-life of just 75 seconds, meaning it clears the body very rapidly. PET cameras detect pairs of photons emitted simultaneously at opposite angles, providing built-in attenuation correction and producing higher-resolution images. According to a 2025 systematic review and meta-analysis published in a peer-reviewed nuclear cardiology journal, the pooled sensitivity of stress myocardial SPECT for coronary artery disease detection is approximately 82%, with a pooled specificity of approximately 74%.

Patients with a higher body mass index, women whose breast tissue may cause attenuation artifacts on SPECT, and patients requiring the fastest testing time are candidates for PET imaging when it is available.

What Is a Nuclear Medicine Stress Test Using Pharmacological Stress Agents?

A pharmacological nuclear stress test is a version of the procedure in which medications rather than physical exercise are used to increase coronary blood flow, replicating the cardiovascular demands that exercise places on the heart.

Not every patient can exercise adequately on a treadmill. Orthopedic injuries, peripheral artery disease, severe deconditioning, neurological conditions, and baseline ECG abnormalities that make exercise ECG interpretation unreliable are all reasons a cardiologist may choose pharmacological stress. According to StatPearls (NCBI), pharmacological agents are used in a substantial proportion of nuclear stress tests, with usage increasing among older patients.

Three main pharmacological stress agents are used in clinical practice:

• Regadenoson (Lexiscan): A selective A2A adenosine receptor agonist. It causes coronary vasodilation by mimicking the effect of endogenous adenosine on the coronary circulation. Normal arteries dilate widely; narrowed arteries cannot dilate proportionally, creating a relative perfusion deficit. Common side effects include flushing, chest pressure, headache, and shortness of breath. These are short-lived due to regadenoson’s short half-life and typically resolve within minutes.
• Adenosine (Adenoscan): A non-selective adenosine receptor agonist with similar vasodilatory effects but more side effects, including bronchospasm. The FDA issued a 2013 warning that both regadenoson and adenosine should not be used in patients with signs of unstable angina or hemodynamic instability.
• Dobutamine: A beta-1 adrenergic agonist that increases heart rate and myocardial contractility, mimicking the metabolic demands of exercise without coronary vasodilation. Used when adenosine-based agents are contraindicated: typically in patients with significant reactive airway disease or severe bronchospasm risk. Aminophylline, an adenosine receptor antagonist, is kept at the bedside during adenosine or regadenoson infusions as a reversal agent if significant adverse effects occur.

Caffeine blocks adenosine receptors and will blunt the vasodilatory effect of adenosine and regadenoson. Patients scheduled for pharmacological nuclear stress testing must avoid all caffeine, including coffee, tea, cola, chocolate, and certain medications, for at least 24 hours before the test.

Key Takeaway: SPECT is the most widely available nuclear stress test format, using Tc-99m-sestamibi or tetrofosmin and a rotating gamma camera. PET provides higher resolution with lower radiation and faster acquisition but requires on-site rubidium infrastructure. Pharmacological agents like regadenoson replace exercise when treadmill testing is not feasible.

This is also helpful: Can Stress Cause Ulcers? What the Science Shows in 2026

How to Prepare for a Nuclear Stress Test

Preparing correctly for a nuclear stress test is essential because several common foods, drinks, and medications directly interfere with the accuracy of the results.

The most important preparation restriction is caffeine. Because pharmacological stress agents including adenosine and regadenoson work by stimulating adenosine receptors in the coronary circulation, caffeine (which blocks those same receptors) will reduce or eliminate the vasodilatory response. The American Society of Nuclear Cardiology (ASNC) guidelines state that patients scheduled for vasodilator pharmacological stress testing must abstain from all caffeine-containing products for at least 24 hours before the test, and some protocols require 48 hours.

Preparation checklist before your nuclear stress test:

1. Caffeine: Avoid coffee, tea, cola beverages, energy drinks, chocolate, and caffeine-containing medications for 24 to 48 hours depending on your protocol.
2. Fasting: Do not eat or drink anything (except water) for 4 to 6 hours before the test. If your appointment is early morning, nothing after midnight is standard.
3. Medications to discuss with your cardiologist: Beta-blockers (such as metoprolol, atenolol, carvedilol) and calcium channel blockers (such as diltiazem, verapamil) slow heart rate and may be held before exercise stress portions of the test. Your cardiologist will tell you specifically which medications to continue and which to hold.
4. Diabetic patients: If you take insulin, discuss with your cardiologist how to adjust your dose around the fasting period. Juice may be permitted in the morning with a reduced insulin dose depending on institutional protocol.
5. Inhalers: Bring your bronchodilator inhaler to the test. Inform the staff. Adenosine and dipyridamole can trigger bronchospasm in susceptible patients; dobutamine may be used instead if you have significant reactive airway disease.
6. Clothing: Wear comfortable, loose-fitting clothing and flat shoes appropriate for walking. Even if you are scheduled for a pharmacological stress test, comfortable clothing is preferred for ECG lead placement.
7. Driving: You can generally drive yourself home after the test. The medications used do not cause sedation. Confirm this with your specific facility, as protocols vary.

For older adults with renal impairment or prior contrast reactions, note that nuclear tracers are distinct from iodinated contrast agents used in CT scans or angiograms. An allergy to CT contrast does not automatically disqualify someone from nuclear stress testing; discuss your history with your cardiologist.

Nuclear Stress Test: What to Expect on the Day

On the day of your nuclear stress test, you will spend most of the time waiting: waiting for the tracer to absorb, waiting between image sets, and waiting while the nuclear cardiologist reviews preliminary images.

Arrive at the nuclear cardiology or nuclear medicine department at the scheduled time. A nurse will review your medical history, confirm your medication and fasting status, and place an intravenous (IV) line in your arm. ECG monitoring electrodes will be attached to your chest to track heart rhythm and rate throughout the procedure.

The resting phase begins with the first tracer injection. You will be asked to lie still on an imaging table for 30 to 60 minutes while the tracer circulates through the coronary arteries and absorbs into the heart muscle. The gamma camera then rotates slowly around your chest, capturing images from multiple angles over approximately 15 to 20 minutes. You will not feel anything from the camera itself.

What the stress phase feels like depends on whether you exercise or receive a pharmacological agent. On the treadmill, the speed and incline increase gradually every 3 minutes following a standard Bruce Protocol until you reach your target heart rate (typically 85% of your age-predicted maximum). If you receive regadenoson or adenosine instead, you may feel a brief flush of warmth, mild chest heaviness, or a sense of breathlessness for 30 to 60 seconds as the medication takes effect. These sensations are expected and resolve quickly. A second tracer injection is given at peak stress.

Physical sensations you may notice during pharmacological stress:

• A warm or flushing sensation in the face or chest
• Mild chest pressure or tightness that resolves within 1 to 2 minutes
• Brief shortness of breath or a sensation of needing to breathe deeply
• Mild headache
• An irregular heartbeat (palpitations) that self-resolves

After the stress tracer injection, you may be offered a light snack to facilitate hepatic tracer clearance before the final image set. The stress images are then acquired in the same fashion as the resting images.

How Long Does a Nuclear Stress Test Take?

A nuclear stress test typically takes 3 to 4 hours from the time of arrival to the completion of the final image set, though the actual imaging itself accounts for less than an hour of that time.

The extended duration is almost entirely due to waiting for the radioactive tracer to absorb adequately into the heart muscle before images can be taken. Tc-99m-sestamibi and tetrofosmin require 30 to 60 minutes of uptake time. Thallium-201 requires longer. The rest and stress images are taken sequentially, each requiring an additional 15 to 25 minutes under the gamma camera.

PET nuclear stress tests, which use rubidium-82 with its 75-second half-life, are substantially faster. A PET myocardial perfusion study can be completed in under 1 hour because the tracer clears rapidly enough that rest and stress images can be acquired in close succession without long waiting periods.

Some institutions perform a 1-day SPECT protocol where rest and stress imaging occur in the same visit, with a higher tracer dose given for the stress injection to compensate for residual signal from the first dose. Other centers schedule two separate visits for rest and stress imaging to minimize this signal overlap. Your cardiologist’s team will tell you which protocol is planned.

Key Takeaway: Total test time is typically 3 to 4 hours for SPECT and under 1 hour for PET, with most of the SPECT time spent waiting for tracer absorption rather than in active imaging. Bring reading material and plan to rest comfortably.

What Does a Nuclear Stress Test Look for in the Images?

A nuclear cardiologist reads the stress and rest perfusion images looking for differences in radiotracer uptake between heart muscle regions, patterns of reduced uptake at stress, and changes in left ventricular size and function.

Normally, a healthy heart with unobstructed coronary arteries shows uniform, bright tracer uptake throughout the left ventricular wall on both the rest and stress images. No dark zones. No asymmetry. The left ventricular cavity stays the same size or slightly smaller at stress compared to rest. Ejection fraction either stays the same or rises slightly.

An abnormal finding typically appears as a region of reduced tracer uptake: an area that is noticeably darker than surrounding muscle on one or both image sets. The nuclear cardiologist quantifies these findings using standardized scoring systems:

• Summed Stress Score (SSS): A numerical score of perfusion across all left ventricular segments during stress. Higher scores indicate larger or more severe perfusion deficits.
• Summed Rest Score (SRS): The same scoring applied to resting images, indicating fixed defects from scar tissue.
• Summed Difference Score (SDS): The mathematical difference between SSS and SRS. A high SDS indicates that much of the stress deficit is reversible (ischemia rather than scar).

Beyond perfusion maps, gated SPECT and PET images also show wall motion: whether each region of the heart muscle contracts normally with each heartbeat. Areas of ischemia or infarction may move poorly or not at all during systole.

According to the Journal of Nuclear Cardiology, a Summed Stress Score of 0 to 3 is generally considered normal. Scores of 4 to 8 indicate mild ischemia. Scores above 8 indicate moderate to severe ischemia and typically prompt further evaluation or intervention.

Does a Nuclear Stress Test Show Blocked Arteries?

A nuclear stress test does not directly image coronary arteries or show where a specific blockage is located; instead, it shows the downstream consequence of reduced blood flow in the heart muscle supplied by that artery.

This is an important distinction. Coronary angiography (a catheter-based procedure) directly visualizes coronary artery anatomy and can identify a specific narrowing at a specific location in a specific artery. A nuclear stress test does not do this. What it shows is whether the muscle downstream from any given artery is receiving adequate blood flow under stress conditions.

Think of it this way: a traffic sensor on a highway does not tell you exactly where the accident is. It tells you that cars are not moving past a certain point. The nuclear stress test is the traffic sensor. Coronary angiography is the helicopter view that shows the accident itself.

That said, an experienced nuclear cardiologist can often infer which coronary artery territory is affected by the location of the perfusion deficit. The left anterior descending artery (LAD) supplies the front wall and apex of the left ventricle. The right coronary artery (RCA) supplies the inferior wall. The left circumflex artery (LCX) supplies the lateral wall. A perfusion deficit in the anterior wall most commonly suggests LAD territory ischemia, though this inference is probabilistic rather than definitive.

What a nuclear stress test can show about coronary arteries:

• Evidence of reduced blood flow in a specific coronary territory at stress
• Differentiation between myocardial ischemia (flow problem) and scar tissue (structural damage)
• Estimated extent and severity of coronary blood flow restriction
• Left ventricular function at rest and stress, which deteriorates with significant coronary disease

What it cannot show:

• The precise anatomical location of a coronary artery narrowing
• The exact percentage of stenosis in a specific vessel
• Plaque composition (stable vs. vulnerable plaque)
• Vessels with diffuse mild disease (balanced ischemia can produce a falsely normal scan)

Key Takeaway: A nuclear stress test reveals whether heart muscle is being starved of blood under stress and how much muscle is affected. It does not directly image coronary arteries. A cardiologist uses it alongside clinical history, ECG, and risk factors to decide whether coronary angiography is warranted.

How Accurate Are Nuclear Stress Tests?

Nuclear stress tests with SPECT myocardial perfusion imaging have a pooled sensitivity of approximately 82% and a pooled specificity of approximately 74% for detecting obstructive coronary artery disease, based on a 2025 systematic review and meta-analysis of 104 studies published in the cardiology literature.

Sensitivity of 82% means the test correctly identifies approximately 82 out of 100 patients with significant coronary artery disease. Specificity of 74% means it correctly identifies approximately 74 out of 100 patients who do not have the disease as normal. In plain terms: SPECT nuclear stress testing is good but not perfect. It will miss some cases of coronary artery disease (false negatives), and it will flag some people as abnormal who do not actually have obstructive disease (false positives).

A related guide: Does Stress Delay Your Period? Science Explained 2026

PET myocardial perfusion imaging performs somewhat better. The same 2025 meta-analysis placed PET’s diagnostic performance at approximately 83% sensitivity for detecting significant coronary artery stenosis, with higher specificity due to built-in attenuation correction.

For comparison: coronary CT angiography (CCTA) has higher sensitivity (approximately 94%) but lower positive predictive value in populations with a lower pre-test probability of disease, making it most useful in lower-risk patients with atypical symptoms.

These figures reflect performance in mixed populations. Accuracy varies by patient population, the prevalence of coronary artery disease in the group being tested, and how severely stenosed the arteries are. For lesions with greater than 60% stenosis, SPECT sensitivity rises toward 98%, according to data published in the Journal of Nuclear Medicine.

Nuclear Stress Test False Positive Rates and Sex-Specific Accuracy

False positive nuclear stress test results occur when the perfusion images show apparent defects that do not reflect actual coronary artery disease, and this is more common in specific populations than most patient-facing resources acknowledge.

The most clinically relevant source of false positive results in SPECT imaging is attenuation artifact: a reduction in detected radiotracer signal caused by overlying tissue absorbing some of the gamma photons before they reach the camera. In women, breast tissue can attenuate photons traveling from the anterior (front) wall of the left ventricle, creating an apparent anterior perfusion defect that does not correspond to any real ischemia or blockage.

According to a review published in Circulation (American Heart Association), false positive SPECT results due to soft tissue attenuation from breast tissue or body habitus are a recognized limitation of standard SPECT imaging in women. A study published in the Journal of the American College of Cardiology (PROMISE trial analysis) found that false positive rates for nuclear stress testing in women without known coronary artery disease may be approximately 28%, compared to substantially lower rates in men under the same conditions.

What can be done about false positive results in women:

• Software-based attenuation correction can reduce artifact frequency but does not eliminate it
• PET imaging with built-in hardware attenuation correction provides more accurate results in women
• Prone imaging (lying face-down during SPECT acquisition) shifts breast tissue away from the heart and may improve specificity
• Stress echocardiography does not have the same breast-attenuation problem and may be preferred in some women

Obesity also affects SPECT accuracy. A very large body habitus attenuates photons from the inferior (bottom) wall of the left ventricle, which can create spurious inferior defects that mimic the distribution of right coronary artery disease. PET imaging largely resolves this limitation.

For women with an abnormal anterior wall finding on SPECT, it is worth asking the nuclear cardiologist whether the finding is consistent with breast attenuation artifact or whether additional imaging (attenuation-corrected SPECT or PET) would help clarify the result before proceeding to coronary angiography.

Nuclear Stress Test Results Explained: Reversible vs. Fixed Defects

The most clinically meaningful distinction in nuclear stress test results is whether an abnormal perfusion finding is reversible (present at stress but absent at rest) or fixed (present at both stress and rest).

This distinction matters because it tells your cardiologist whether the heart muscle in question is still alive and capable of recovering if blood flow is restored, or whether it has been permanently damaged.

A reversible perfusion defect appears as reduced tracer uptake in a specific region of the heart on the stress images but normal or near-normal uptake in the same region on the resting images. This pattern indicates that the muscle is alive and receives enough blood at rest, but becomes ischemic during increased demand. Reversible defects point to a coronary artery with a flow-limiting stenosis that reduces perfusion reserve. This is the finding most likely to prompt consideration of revascularization.

A fixed perfusion defect appears as reduced tracer uptake in the same region on both the stress and the resting images. The muscle absorbs the tracer poorly at both time points. This pattern most often indicates myocardial infarction scar: tissue that was permanently damaged by a prior heart attack and has been replaced by fibrous tissue that no longer contracts or uses blood flow.

Your result report will also include the left ventricular ejection fraction (LVEF). A normal resting LVEF is 55% or above. Values below 50% at rest suggest impaired pumping function and warrant further evaluation. A drop in LVEF from rest to stress is particularly concerning and typically triggers urgent cardiology follow-up.

Key Takeaway: A reversible defect means viable but ischemic muscle that might benefit from a procedure to open the narrowed artery. A fixed defect means scar. Your cardiologist uses the size, location, and reversibility of any defect along with ejection fraction data to decide what comes next.

What Happens After an Abnormal Nuclear Stress Test?

An abnormal nuclear stress test result triggers a structured clinical pathway that depends on the size of the defect, the degree of reversibility, the ejection fraction, and your overall clinical picture.

A small reversible defect in a patient with well-controlled symptoms, preserved ejection fraction, and a low-risk clinical profile may be managed with optimized medical therapy: typically a combination of antiplatelet agents, a statin, a beta-blocker, and an ACE inhibitor or ARB, along with lifestyle modification. The American College of Cardiology and the American Heart Association stable ischemic heart disease guidelines support this approach for many patients with stable, moderate ischemia, noting that medical therapy provides outcomes equivalent to revascularization for a significant proportion of stable patients.

A moderate to large reversible defect, a drop in ejection fraction during stress, multiple perfusion territories involved, or a very high Summed Stress Score (above 8 to 10) typically prompts referral for coronary angiography: a catheter-based procedure that directly images the coronary arteries and can localize and quantify any stenosis. During angiography, the cardiologist may also perform fractional flow reserve (FFR) measurement, a pressure-wire technique that determines whether a specific stenosis is actually limiting blood flow enough to cause ischemia.

What happens after an abnormal result:

• Mild defect, preserved LVEF, single vessel territory: Optimized medical therapy may be the first step, with repeat imaging in 1 to 2 years
• Moderate-large reversible defect: Cardiology referral for coronary angiography to determine anatomy and whether revascularization (stenting or bypass surgery) would help
• Fixed defect, reduced LVEF below 35%: Urgent evaluation for heart failure management; electrophysiology referral may be needed
• High-risk scan features (very large defect, LVEF drop at stress, transient ischemic dilation): Expedited cardiology evaluation; may warrant urgent angiography within days to weeks

If you receive an abnormal nuclear stress test result and your ordering physician has not discussed the next steps within a few days, contact the office proactively. Ask specifically: Is this a high-risk or low-risk result? Does the finding warrant coronary angiography? Has a cardiology referral been placed? These are the exact questions a board-certified cardiologist reviewing your images would want you to know to ask.

Frequently Asked Questions About Nuclear Stress Tests

What is a nuclear stress test and why is it done?

A nuclear stress test is a cardiac imaging procedure that uses a radioactive tracer and a specialized camera to show how well blood flows through the heart muscle at rest and under stress. It is ordered to diagnose coronary artery disease, assess the severity of known coronary disease, evaluate symptoms like chest pain or shortness of breath, and determine whether prior treatments like stenting or bypass surgery are working. The test provides information about both blood flow and heart pumping function that a standard ECG stress test alone cannot deliver.

How long does a nuclear stress test take from start to finish?

A standard SPECT nuclear stress test takes approximately 3 to 4 hours from arrival to completion of the final images, though the actual imaging itself takes less than an hour. Most of the time is spent waiting for the radioactive tracer to absorb into the heart muscle before images can be taken. PET nuclear stress tests are much faster, typically completed in under 1 hour, because the rubidium-82 tracer has a very short half-life that allows rapid sequential imaging.

Does a nuclear stress test show blocked arteries?

A nuclear stress test does not directly image coronary arteries or show the exact location of a blockage. It shows whether the heart muscle downstream from a coronary artery is receiving adequate blood flow under stress conditions, and it identifies which coronary territory appears affected. If the test reveals significant ischemia, a cardiologist will typically order coronary angiography, which directly visualizes coronary artery anatomy and can precisely locate and measure any stenosis.

What should I avoid before a nuclear stress test?

Avoid all caffeine, including coffee, tea, cola, energy drinks, chocolate, and caffeine-containing medications, for at least 24 to 48 hours before the test, particularly if you are scheduled for pharmacological stress testing. Do not eat or drink anything except water for 4 to 6 hours before the test. Ask your cardiologist which medications to hold: beta-blockers and certain calcium channel blockers may be paused before exercise protocols, while specific heart medications should be continued; your clinical team will give you individualized instructions.

How accurate is a nuclear stress test at detecting heart disease?

Stress SPECT myocardial perfusion imaging has a pooled sensitivity of approximately 82% and a pooled specificity of approximately 74% for detecting obstructive coronary artery disease, according to a 2025 systematic review of 104 studies. This means the test correctly identifies about 82% of patients who actually have significant disease, and about 74% of those without significant disease. PET imaging performs similarly in sensitivity but with higher specificity, particularly in patients with obesity or in women where breast tissue can interfere with SPECT image quality.

What happens if my nuclear stress test comes back abnormal?

The appropriate next step after an abnormal nuclear stress test depends on the size of the perfusion defect, whether it is reversible or fixed, and your ejection fraction. A small or mild finding in a stable patient may be managed with optimized medical therapy and monitoring, while a moderate to large reversible defect typically prompts referral for coronary angiography to directly assess the coronary arteries. Contact your ordering physician promptly if you have not received a clear plan within a few days, and ask your cardiologist specifically whether the finding is low-risk or high-risk and whether a cardiology referral has been placed.

Closing

A nuclear stress test gives your cardiologist a functional map of your heart’s blood supply under real demand conditions. That map is more informative than resting ECG alone, and for patients with intermediate coronary artery disease risk, it is one of the most useful tools available for deciding whether observation, medication adjustment, or a procedure is the right next move.

If you are preparing for this test, the single most actionable step you can take is eliminating caffeine for 24 to 48 hours before your appointment, especially if your test includes a pharmacological stress agent. A missed caffeine restriction is one of the most common reasons for a non-diagnostic or falsely reassuring test.

Another useful guide: Stress and Memory: What the Research Really Shows (2026)

When your results come back, do not walk away until you understand two things: whether any defect found is reversible or fixed, and what the planned next step is based on that finding. You now have the information to ask exactly that.